UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 6-K
____________________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
June 30, 2016
____________________________
Lombard Medical, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Commission File Number 001-36402
____________________________
N/A
(Translation of Registrant’s Name into English)
____________________________
Cayman Islands
(State or Other Jurisdiction of
Incorporation or Organization) | 3841
(Primary Standard Industrial
Classification Code Number) | Not applicable
(I.R.S. Employer Identification
Number) |
6440 Oak Canyon
Suite 200
Irvine, CA 92618
+1-866-790-1447
(Address, Including ZIP Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
_______________________
Lombard Medical, Inc.
6440 Oak Canyon
Suite 200
Irvine, CA 92618
(Name, Address of Agent for Service)
_______________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___
Lombard Medical, Inc. (the “Company”) is announcing today that it plans to hold its 2016 Annual General Meeting of Shareholders (the “Annual Meeting”) on August 2, 2016 at 10:00 a.m., Pacific Time, at the Company’s U.S. office located at 6440 Oak Canyon, Suite 200, Irvine, California 92618.
Pursuant to the Company’s Amended and Restated Memorandum and Articles of Association, the Company will mail a notice of Annual Meeting accompanied by a proxy statement to the Company’s shareholders of record as of July 1, 2016, at least 10 days prior to the date of the Annual Meeting, copies of which will be filed upon mailing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | Lombard Medical, Inc. |
| | | | |
| | | | |
| Date: June 30, 2016 | By: | /s/ William J. Kullback | |
| | | William J. Kullback | |
| | | Chief Financial Officer |
